Casein kinase II inhibition induces apoptosis in pancreatic cancer cells

Oncology Reports

Volumn 18, Issue 3, 2007, Pages 695-701

  Hamacher, Rainer ^a   Saur, Dieter ^a   Fritsch, Ralph ^a   Reichert, Maximilian ^a   Schmid, Roland M ^a   Schneider, Günter ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Apoptosis; Casein kinase II; NF B; Pancreatic cancer

Indexed keywords

CASEIN KINASE II; OLIGODEOXYRIBONUCLEOTIDE; PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG ANTAGONISM; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HUMAN; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; CASEIN KINASE II; CELL SURVIVAL; HUMANS; OLIGODEOXYRIBONUCLEOTIDES; PANCREATIC NEOPLASMS; PROTEIN KINASE INHIBITORS; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 38449100168     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.3.695     Document Type: Article

References (42)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ: Cancer Statistics, 2004. CA Cancer J Clin 54: 8-29, 2004. (Pubitemid 38443417)
2. Schneider G, Siveke JT, Eckel F and Schmid RM: Pancreatic cancer: basic and clinical aspects. Gastroenterology 128: 1606-1625, 2005. (Pubitemid 40692555)
3. Lowe SW, Cepero E and Evan G: Intrinsic tumour suppression. Nature 432: 307-315, 2004. (Pubitemid 39551658)
4. Igney FH and Krammer PH: Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2: 277-288, 2002. (Pubitemid 37328781)
5. Schulze-Bergkamen H and Krammer PH: Apoptosis in cancer-implications for therapy. Semin Oncol 31: 90-119, 2004.
6. Gukovskaya AS and Pandol SJ: Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology 4: 567-586, 2004. (Pubitemid 40091409)
7. Kornmann M, Ishiwata T, Kleeff J, Beger HG and Korc M: Fas and Fas-ligand expression in human pancreatic cancer. Ann Surg 231: 368-379, 2000. (Pubitemid 30137125)
8. Ibrahim SM, Ringel J, Schmidt C, Ringel B, Muller P, Koczan D, Thiesen HJ and Lohr M: Pancreatic adenocarcinoma cell lines show variable susceptibility to trail-mediated cell death. Pancreas 23: 72-79, 2001. (Pubitemid 32592079)
9. Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H and Ungefroren H: Bcl-Xl protects pancreatic adenocarcinoma cells against Cd95- and trail-receptor-mediated apoptosis. Oncogene 19: 5477-5486, 2000. (Pubitemid 32000915)
10. Evans JD, Cornford PA, Dodson A, Greenhalf W, Foster CS and Neoptolemos JP: Detailed tissue expression of Bcl-2, Bax, Bak and Bcl-X in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas. Pancreatology 1: 254-262, 2001. (Pubitemid 33674930)
11. Campani D, Esposito I, Boggi U, Cecchetti D, Menicagli M, De Negri F, Colizzi L, Del Chiaro M, Mosca F, Fornaciari G and Bevilacqua G: Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol 194: 444-450, 2001. (Pubitemid 32782669)
12. Litchfield DW: Protein kinase Ck2: structure, regulation and role in cellular decisions of life and death. Biochem J 369: 1-15, 2003.
13. Meggio F and Pinna LA: One-thousand-and-one substrates of protein kinase Ck2? FASEB J 17: 349-368, 2003. (Pubitemid 36292951)
14. Guerra B and Issinger OG: Protein kinase Ck2 and its role in cellular proliferation, development and pathology. Electrophoresis 20: 391-408, 1999. (Pubitemid 29125027)
15. Tawfic S, Yu S, Wang H, Faust R, Davis A and Ahmed K: Protein kinase Ck2 signal in neoplasia. Histol Histopathol 16: 573-582, 2001. (Pubitemid 32297655)
16. Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, Hochmann A, Journot L, Antonsson B and Martinou JC: Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell 8: 601-611, 2001. (Pubitemid 32946937)
17. Li PF, Li J, Muller EC, Otto A, Dietz R and von Harsdorf R: Phosphorylation by protein kinase Ck2: a signaling switch for the caspase-inhibiting protein arc. Mol Cell 10: 247-258, 2002. (Pubitemid 35007340)
18. Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F and Sonenshein GE: Roles of Ikk kinases and protein kinase Ck2 in activation of nuclear factor-kappab in breast cancer. Cancer Res 61: 3810-3818, 2001. (Pubitemid 32694998)
19. Shen J, Channavajhala P, Seldin DC and Sonenshein GE: Phosphorylation by the protein kinase Ck2 promotes calpain-mediated degradation of Ikappabalpha. J Immunol 167: 4919-4925, 2001. (Pubitemid 33009721)
20. Romieu-Mourez R, Landesman-Bollag E, Seldin DC and Sonenshein GE: Protein kinase Ck2 promotes aberrant activation of nuclear factor-kappab, transformed phenotype, and survival of breast cancer cells. Cancer Res 62: 6770-6778, 2002. (Pubitemid 35364150)
21. Kato T Jr, Delhase M, Hoffmann A and Karin M: Ck2 is a C-terminal Ikappab kinase responsible for NF-kappab activation during the UV response. Mol Cell 12: 829-839, 2003. (Pubitemid 37352777)
22. Tapia JC, Torres VA, Rodriguez DA, Leyton L and Quest AF: Casein kinase 2 (Ck2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc Natl Acad Sci USA 103: 15079-15084, 2006. (Pubitemid 44583167)
23. Guo C, Yu S, Davis AT, Wang H, Green JE and Ahmed K: A potential role of nuclear matrix-associated protein kinase Ck2 in protection against drug-induced apoptosis in cancer cells. J Biol Chem 276: 5992-5999, 2001.
24. Ravi R and Bedi A: Sensitization of tumor cells to Apo2 ligand/trail-induced apoptosis by inhibition of casein kinase II. Cancer Res 62: 4180-4185, 2002. (Pubitemid 34827267)
25. Izeradjene K, Douglas L, Delaney A and Houghton JA: Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Clin Cancer Res 10: 6650-6660, 2004. (Pubitemid 39346562)
26. Farah M, Parhar K, Moussavi M, Eivemark S and Salh B: 5,6-Dichloro-ribofuranosylbenzimidazole- and Apigenin-induced sensitization of colon cancer cells to Tnf-alpha-mediated apoptosis. Am J Physiol Gastrointest Liver Physiol 285: G919-G928, 2003. (Pubitemid 37310071)
27. Izeradjene K, Douglas L, Delaney A and Houghton JA: Casein kinase II (Ck2) enhances death-inducing signaling complex (Disc) activity in trail-induced apoptosis in human colon carcinoma cell lines. Oncogene 24: 2050-2058, 2005. (Pubitemid 40516198)
28. Haussler U, von Wichert G, Schmid RM, Keller F and Schneider G: Epidermal growth factor activates nuclear Factor-kappab in human proximal tubule cells. Am J Physiol Renal Physiol 289: F808-F815, 2005. (Pubitemid 41324202)
29. Padmanabha R, Chen-Wu JL, Hanna DE and Glover CV: Isolation, sequencing and disruption of the yeast Cka2 gene: casein kinase II is essential for viability in saccharomyces cerevisiae. Mol Cell Biol 10: 4089-4099, 1990.
30. Ahmed K, Gerber DA and Cochet C: Joining the cell survival squad: an emerging role for protein kinase Ck2. Trends Cell Biol 12: 226-230, 2002. (Pubitemid 34327615)
31. Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger OG and Boldyreff B: Disruption of the regulatory beta subunit of protein kinase Ck2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 23: 908-915, 2003. (Pubitemid 36133509)
32. Giroux V, Iovanna J and Dagorn JC: Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance. FASEB J 20: 1982-1991, 2006. (Pubitemid 44953898)
33. Ruzzene M, Penzo D and Pinna LA: Protein kinase Ck2 inhibitor 4,5,6,7-tetrabromobenzotriazole (Tbb) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (Hs1) in jurkat cells. Biochem J 364: 41-47, 2002. (Pubitemid 34538944)
34. Faust RA, Tawfic S, Davis AT, Bubash LA and Ahmed K: Antisense oligonucleotides against protein kinase Ck2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro. Head Neck 22: 341-346, 2000. (Pubitemid 30413298)
35. Yang BF, Xiao C, Roa WH, Krammer PH and Hao C: Calcium/calmodulin- dependent protein kinase II regulation of C-Flip expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells. J Biol Chem 278: 7043-7050, 2003. (Pubitemid 36800700)
36. Slaton JW, Unger GM, Sloper DT, Davis AT and Ahmed K: Induction of apoptosis by antisense Ck2 in human prostate cancer xenograft model. Mol Cancer Res 2: 712-721, 2004.
37. Arlt A, Vorndamm J, Breitenbroich M, Folsch UR, Kalthoff H, Schmidt WE and Schafer H: Inhibition of Nf-kappab sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (Vp16) or doxorubicin. Oncogene 20: 859-868, 2001. (Pubitemid 32198179)
38. Thomas RP, Farrow BJ, Kim S, May MJ, Hellmich MR and Evers BM: Selective targeting of the nuclear factor-kappab pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Surgery 132: 127-134, 2002. (Pubitemid 35024752)
39. Muerkoster S, Arlt A, Witt M, Gehrz A, Haye S, March C, Grohmann F, Wegehenkel K, Kalthoff H, Folsch UR and Schafer H: Usage of the Nf-kappab inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer 104: 469-476, 2003. (Pubitemid 36323918)
40. Sato T, Odagiri H, Ikenaga SK, Maruyama M and Sasaki M: Chemosensitivity of human pancreatic carcinoma cells is enhanced by Ikappabalpha super-repressor. Cancer Sci 94: 467-472, 2003. (Pubitemid 36790481)
41. Wang D, Westerheide SD, Hanson JL and Baldwin AS Jr: Tumor necrosis factor alpha-induced phosphorylation of Rela/P65 on Ser529 is controlled by casein kinase II. J Biol Chem 275: 32592-32597, 2000.
42. Shin S, Lee Y, Kim W, Ko H, Choi H and Kim K: Caspase-2 primes cancer cells for trail-mediated apoptosis by processing procaspase-8. EMBO J 24: 3532-3542, 2005. (Pubitemid 41509361)